Psychiatr. pro Praxi, 2008; 9(4): 170-173

Metabolic syndrome and SELECTED MENTHAL ILLNESSES

doc. MUDr. Miroslav Zeman CSc1, doc. MUDr. Roman Jirák CSc2
1 IV. interní klinika VFN a 1. LF UK, Praha
2 Psychiatrická klinika 1. LF UK a VFN Praha

Metabolic syndrome, characterized by coincidental occurence of several risk factors of cardiovascular diseases, is connected not only with an increased risk of ischaemic heart disease and other complications of atherosclerosis but also with other diseases such as type 2 diabetes mellitus or some malignancies (e. g. colorectal, prostate or pancreatic cancer). Nowadays, the connection between metabolic syndrome and some neurologic and psychiatric diseases (especially schizophrenia, depressive disorder and Alzheimer´s disease) is disputed. The article outlines the relationship between metabolic syndrome on one hand and selected mental diseases on the other hand. Possible participating mechanism in the background are discusses.

Keywords: Key words: metabolic syndrome, schizophrenia, depressive disorder, Alzheimer´s disease, insulin resistance.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zeman M, Jirák R. Metabolic syndrome and SELECTED MENTHAL ILLNESSES. Psychiatr. praxi. 2008;9(4):170-173.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr. Med. Res. Opin. 2005, 8: 1157-1159. Go to original source... Go to PubMed...
    2. Bloomgarden ZT. Definitions of the insulin resistance syndrome. Diabetes Care 2004; 27: 824-830. Go to original source... Go to PubMed...
    3. Cífková R. Epidemiologie metabolického syndromu ve světě a v České republice. Ústní sdělení na Symposiu o syndromu inzulinové rezistence, Praha 26-27. února 2003.
    4. Eckel RH, GrundySM, Zimmet PZ. The metabolic syndrome. Lancet 2005, 365: 1415-1428. Go to original source... Go to PubMed...
    5. Enger C, Weatherby L, Reynolds RF et al. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 2004; 192: 19-27. Go to original source... Go to PubMed...
    6. Hartmann T, Kuchenbecker J, Grimm M.O.W. Alzheimer´s disease: the lipid connection. J. Neurochem. 2007, 103 (Suppl.1): 159-170. Go to original source... Go to PubMed...
    7. Jirák R, Koukolík F. Demence. Praha: Galén 2004, 335 s.
    8. Juany TL, Zandi PP, Tucker KL et al. Benefits of fatty fish of dementia risk are stronger for those without APOE E4. Neurology 2005; 65: 1409-1414. Go to original source... Go to PubMed...
    9. Kato MM, Currier MB, Gomez CM et al. Prevalence of metabolic syndrome in Hispanic and NonHispanic patients with schizophrenia. Prim Care Companion J Clin Psychiatry 2004; 6: 74-77. Go to original source... Go to PubMed...
    10. Kinder LS, Carnethon MR, Palaniappan LP et al. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom. Med. 2004, 66: 316-322. Go to original source... Go to PubMed...
    11. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63: 1187-1192. Go to original source... Go to PubMed...
    12. McCaffery JM, Niaura R, Todaro JF et al. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute Twin Study. Psychosom. Med. 2003, 65: 490-497. Go to original source... Go to PubMed...
    13. Přikryl R. Poruchy kognitivních funkcí u pacientů s diabetem mellitem. Časopis lékařů českých, 2007;146: 434-437. Go to PubMed...
    14. Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol. 2007, 64: 93-96. Go to original source... Go to PubMed...
    15. Ryan MCM, Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 2002; 71: 239-257. Go to original source... Go to PubMed...
    16. Ryan MCM, Collins P, Thakore JH. Impaired fasting glukose-tolerance in first-episode, drugnaive patiens with schizophrenia. Am. J. Psychiatry 2003, 160: 284-289. Go to original source... Go to PubMed...
    17. Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000; 48: 755-765. Go to original source... Go to PubMed...
    18. Suvisaari JM, Sarni SI, Perala J. et al. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry. 2007; 68(7): 1045. Go to original source... Go to PubMed...
    19. Tschoner A, Engl J, Laimer M et al. Metabolic side-effects of antipsychotic medication. Int. J. Clin. Pract. 2007; 61: 1356-1370 Go to original source... Go to PubMed...
    20. Vaidya VA, Duman RS. Depression-emerging insights from neurobiology. Br. Med. Bull. 2001, 57: 61-79. Go to original source... Go to PubMed...
    21. Vanhanen M, Koivisto K, Moilanen L et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006, 67: 843-847. Go to original source... Go to PubMed...
    22. Watson GS, Bernhardt T, Reger MA et al. Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiology of Aging 2006; 27: 38-41. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.